AVITA MEDICAL INC (RCEL) Stock Income Statement
NASDAQ:RCEL - Nasdaq - US05380C1027 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 71.66M | 64.25M | 50.14M | 34.42M | 29.23M | |||
| Cost Of Goods | 9.70M | 8.61M | 7.56M | 5.67M | 5.72M | |||
| Gross Profit | 61.96M | 55.64M | 42.58M | 28.76M | 23.51M | |||
| Operating Expenses | 112.54M | 111.64M | 84.93M | 55.88M | 49.82M | |||
| Research and Development | 21.45M | 20.36M | 20.82M | 13.86M | 14.82M | |||
| Selling, General, and Administrative Expenses | 91.09M | 91.28M | 65.54M | 45.24M | 37.06M | |||
| Operating Income | -50.58M | -56.00M | -42.35M | -27.13M | -26.31M | |||
| Interest Income/Expense | -5.24M | -5.36M | -1.14M | -20.00K | -20.00K | |||
| Other Income/Expense | -563.00K | 163.00K | 8.48M | 890.00K | 20.00K | |||
| Non Recurring Items | -635.00K | -594.00K | -308.00K | -380.00K | -230.00K | |||
| Income Before Taxes | -57.01M | -61.79M | -35.31M | -26.63M | -26.55M | |||
| Income Tax | 32.00K | 54.00K | 66.00K | 40.00K | 40.00K | |||
| Net Income | -57.05M | -61.84M | -35.38M | -26.67M | -26.58M | |||
| EBITDA | -49.13M | -54.87M | -41.72M | -26.56M | -25.59M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.19 | -2.39 | -1.40 | -1.07 | -1.17 | |||
| Non GAAP EPS | -2.19 | -2.39 | -1.40 | -1.07 | -1.17 | |||
| Statistics | ||||||||
| Gross Profit Margin | 86.47% | 86.60% | 84.93% | 83.56% | 80.43% | |||
| Profit Margin | -79.61% | -96.26% | -70.56% | -77.48% | -90.93% | |||
| Operating Profit Margin | -70.58% | -87.16% | -84.45% | -78.82% | -90.01% | |||
All data in USD